What is a stock summary page? Click here for an overview.
Business Description
Vectus Biosystems Ltd
ISIN : AU000000VBS9
Description
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. It operates in one segment, being pharmaceutical research and development.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.93 | |||||
| Equity-to-Asset | 0.33 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.4 | |||||
| 3-Year EPS without NRI Growth Rate | 35.9 | |||||
| 3-Year FCF Growth Rate | 30.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.93 | |||||
| 9-Day RSI | 97.33 | |||||
| 14-Day RSI | 89.2 | |||||
| 3-1 Month Momentum % | -2.6 | |||||
| 6-1 Month Momentum % | -6.25 | |||||
| 12-1 Month Momentum % | -70.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.48 | |||||
| Quick Ratio | 1.48 | |||||
| Cash Ratio | 0.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.9 | |||||
| Shareholder Yield % | 0.96 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -145.67 | |||||
| ROA % | -95.14 | |||||
| ROIC % | -367.21 | |||||
| 3-Year ROIIC % | 19.91 | |||||
| ROC (Joel Greenblatt) % | -577.66 | |||||
| ROCE % | -143.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 10 | |||||
| Price-to-Tangible-Book | 8 | |||||
| EV-to-EBIT | -1.7 | |||||
| EV-to-EBITDA | -1.74 | |||||
| EV-to-FCF | -2.47 | |||||
| Price-to-Net-Current-Asset-Value | 8 | |||||
| Earnings Yield (Greenblatt) % | -58.82 | |||||
| FCF Yield % | -33.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Vectus Biosystems Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.039 | ||
| Beta | 1.37 | ||
| 3-Year Sharpe Ratio | -1.5 | ||
| 3-Year Sortino Ratio | -1.55 | ||
| Volatility % | 62.98 | ||
| 14-Day RSI | 89.2 | ||
| 14-Day ATR (A$) | 0.000272 | ||
| 20-Day SMA (A$) | 0.077 | ||
| 12-1 Month Momentum % | -70.59 | ||
| 52-Week Range (A$) | 0.075 - 0.275 | ||
| Shares Outstanding (Mil) | 53.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vectus Biosystems Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vectus Biosystems Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vectus Biosystems Ltd Frequently Asked Questions
What is Vectus Biosystems Ltd(ASX:VBS)'s stock price today?
The current price of ASX:VBS is A$0.08. The 52 week high of ASX:VBS is A$0.28 and 52 week low is A$0.08.
When is next earnings date of Vectus Biosystems Ltd(ASX:VBS)?
The next earnings date of Vectus Biosystems Ltd(ASX:VBS) is .
Does Vectus Biosystems Ltd(ASX:VBS) pay dividends? If so, how much?
Vectus Biosystems Ltd(ASX:VBS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers